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EDITORIAL
“Doc, Should I Accept This Offer or Not?”
Robert M. Merion
He is a fool who lets slip a bird in the hand for
a bird in the bush.
—Plutarch
Every four hours, a patient dies awaiting a livertransplant.1 This is a stark reality, whether it’s your
father, your wife, your best friend, or one of your favor-
ite patients. The organ shortage continues unabated,
and the quality of the average donor gets worse with
each passing year.
It is in this context that patients and transplant pro-
fessionals are faced with the increasingly difficult deci-
sion, in the middle of the night, whether to accept an
offer of a donor liver with adverse characteristics, such
as advanced donor age, or to eschew that offer and play
the odds that another, more desirable, donor liver will
be offered before the patient dies or becomes too sick to
undergo a transplant with a reasonable expectation of
recovery.
In an ideal world, where donor organs are plentiful
in relation to the number of waiting candidates, such
decisions would not be necessary. But in the real world,
these choices are made on a regular basis. A useful
examination of these issues is offered in this issue of
Liver Transplantation.2 Using Markovian decision anal-
ysis, Amin et al.2 modeled the 1-year survival of candi-
dates who accept a hypothetical expanded criteria
donor liver today and compared it to the survival of
candidates who refuse the offer and continue to wait for
a standard criteria donor.
Conventional wisdom holds that expanded criteria
donor livers should not be used for high risk candidates.
The theory underlying such advice is that the imperfect
function of a transplanted liver will be tolerated poorly
by recipients with advanced disease and other comor-
bidities. Amin et al.2 aver that such proscriptions are
ill-advised. Indeed, the authors suggest that candidates
at high risk of death on the waiting list (model for
end-stage liver disease [MELD] score greater than 30)
would be wise to accept an expanded criteria donor
liver, even if the probability of primary graft failure is
very high. Moreover, the authors suggest that patients
at low risk of death on the waiting list (MELD 11-20)
should also accept expanded criteria donor livers, unless
the risk of primary graft failure is upward of 23%.
Many assumptions underlie the modeling, and it is
worthwhile to highlight some of them in judging the
usefulness of this approach for guiding patient decision
making. Let us consider the following: 1) the definition
of the expanded criteria liver donor; 2) the definition
and outcome of primary graft failure; 3) the use of
1-year survival as an endpoint; 4) limited availability of
posttransplant survival data in the MELD era; and 5)
assumptions about the availability of standard criteria
donor livers.
There is not yet a consensus in the transplant com-
munity regarding the definition of an expanded criteria
liver donor. The abstract presented by Feng et al.3 at last
year’s meeting of the American Association for the
Study of Liver Diseases showed that age alone is not a
predictor of significantly higher risk of graft failure,
with the exception of donors over 70 years of age. Only
when factors in addition to age were added did the
relative risk of graft failure compared to an ideal organ
exceed 1.7. In any event, the acceptance or refusal of an
offer of a given donor organ shouldn’t be cast as a
dichotomous choice between standard and expanded
criteria. There is a broad spectrum of donor quality, and
the important interactions between and among donor
factors and recipient characteristics have not yet been
completely elucidated. Expanded criteria donor livers
are not all created equally.
Amin et al.2 defined primary graft failure as a non-
functioning graft within 1 month after receiving
deceased donor liver transplantation, but also assumed
that 25% of cases had spontaneous recovery. This con-
cept is problematic, since the term “nonfunctioning”
should imply that either patient death or retransplanta-
tion was required. Much of the subsequent results and
interpretation depend on the incidence and outcome of
primary graft failure. Among the 75% that did not have
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spontaneous recovery, it was estimated that 35% would
die and 65% would be retransplanted.
In contrast to early graft failure, concerns have
recently arisen regarding the incidence of late biliary
complications in recipients of less than ideal donor liv-
ers. This may ultimately lead to higher rates of long-
term allograft failure and death, not to mention the
morbidity of biliary strictures; however, patients trans-
planted in the MELD era have not been followed long
enough to generate meaningful inferences from actual
data on this point. The authors’ use of a second order
Monte Carlo simulation provides an elegant way to
partially circumvent the sparse posttransplant mortality
data available for the MELD era, but doesn’t help us
with more long-term analysis.
If the use of expanded criteria donor livers does lead
to much higher rates of retransplantation, it is conceiv-
able that in the long run the overall number of success-
fully transplanted recipients could actually be reduced
by this practice. And even if the transplantation of a
high-risk liver is associated with a better prospect of
survival than no transplant for an individual patient,
perhaps society has an interest in a minimum absolute
survival to ensure optimum use of the scarce supply of
donor organs. This is an issue beyond the scope of the
article, but one which continues to vex the transplant
community.
The article’s conclusions rest upon accurate depic-
tion of the subsequent availability of a standard criteria
donor liver. This question of availability is of para-
mount importance to the patient who is considering an
offer of an expanded criteria donor liver today. A
national average monthly probability of standard crite-
ria donor liver transplant was used, which fails to
account for the vast disparities in transplant access
across the country, even within categories of MELD
score. Further study of this question should include
consideration of local transplant rates before the results
of this important study can be translated into specific
advice for patients awaiting liver transplantation.
Finally, the authors suggest that a major impedi-
ment to more widespread use of expanded criteria
donor livers is the parochial concern of transplant pro-
grams that their publicly-available, center-specific, graft
failure and patient mortality rates will be adversely
affected by the use of these organs. Presently, a number
of donor characteristics are used to generate the
expected failure rates by center reported by the Scien-
tific Registry of Transplant Recipients.4 As the defini-
tion of an expanded criteria donor liver becomes
accepted, it is possible that separate reporting of results
of transplants of such organs could be instituted, as has
been done in deceased donor kidney transplantation.
Ultimately, as our understanding of expanded criteria
donor livers improves, we should be able to better
define the kinds of patients and circumstances in which
these organs are best used. In the meantime, this article
provides useful new insights along the way.
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